UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 4, 2004
Bio-Imaging Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware | 1-11182 | 11-2872047 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
826 Newtown-Yardley Road, Newtown, PA | 18940 | |
(Address of Principal Executive Offices) | (Zip Code) |
(267) 757-3000
(Registrants telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
Exhibit No. |
Description | |
99.1 | Press Release of Bio-Imaging Technologies, Inc. dated August 4, 2004. |
Item 12. Results of Operations and Financial Condition.
On August 4, 2004, Bio-Imaging Technologies, Inc., a Delaware corporation (the Company), issued a press release to report the Companys financial results for the quarter ended June 30, 2004. The full text of the press release is attached to this current report on Form 8-K as Exhibit 99.1.
The information in this Form 8-K shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
- 2 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
BIO-IMAGING TECHNOLOGIES, INC. | ||||
Dated: August 4, 2004 |
By: |
/s/ Mark L. Weinstein | ||
Name: |
Mark L. Weinstein | |||
Title: |
President and Chief Executive Officer |
- 3 -